Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperinsulinism × Diazoxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Endocrine 1 CNS 1

Conditions

Pituitary Diseases 1 Obesity 1 Neoplasms 1 Hypoglycemia 1 Hyperinsulinism 1 Gastro-enteropancreatic neuroendocrine tumor 1 Craniopharyngioma 1

Interventions

fluorodopa F 18 3 pasireotide 1 dapagliflozin 1 amino-acid, glucose, and electrolyte solution 1 Solutions 1 Saline Solution 1 Pioglitazone 1 Insulin 1 Injections 1 Diazoxide 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00306683 2011-02-18

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

CNSEndocrineOther

Craniopharyngioma, Hyperinsulinism, Neoplasms, Obesity, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡